CD44 and breast carcinoma: A different study reported that an amplified expression of CD44+/CD24− and aldehyde dehydrogenase 1 (ALDH1) in breast cancer cell line conferred stemness; which induced anoikis resistance through an increase in the phosphorylation of signal transducers and activators of transcription 3 (STAT3).